Venrock Healthcare Capital Partners III, L.P.

Insider Reports History

Entity
Company
Location
530 Fifth Avenue, 22 Nd Floor, New York, NY
Signature
VHCP Co-Investment Holdings III, LLC, By: VHCP Management III, LLC, Its: Manager, By: /s/ Sherman G. Souther, Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Venrock Healthcare Capital Partners III, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. 10%+ Owner Common Stock 4.82M $70.9M $14.70 Feb 8, 2024 By Funds
KalVista Pharmaceuticals, Inc. 10%+ Owner Pre-Funded Warrants (Right to Buy) 656K $10M $15.25 Feb 20, 2024 By Funds

Insider Reports Filed by Venrock Healthcare Capital Partners III, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Feb 20, 2024 1 $10M 4 Feb 22, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Feb 6, 2024 3 $1.26M 4 Feb 8, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Jan 30, 2024 1 $1.27M 4 Feb 1, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Jan 25, 2024 3 $1.29M 4 Jan 29, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Jan 22, 2024 3 $1.24M 4 Jan 24, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Jan 17, 2024 3 $1.8M 4 Jan 19, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Jan 11, 2024 2 $334K 4 Jan 16, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Jan 8, 2024 3 $1.73M 4 Jan 10, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Jan 3, 2024 2 $721K 4 Jan 5, 2024 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Dec 27, 2023 3 $6.47M 4 Dec 29, 2023 10%+ Owner
KALV KalVista Pharmaceuticals, Inc. Dec 26, 2023 0 $0 3 Dec 28, 2023 10%+ Owner